Open AccessImprovement in Functional Outcomes With Adjunctive Aripiprazole Versus Placebo in Major Depressive Disorder
Author(s) -
Tanya J. Fabian,
Zachary Cain,
Diane Ammerman,
James M. Eudicone,
Yan Tang,
Linda Rollin,
Robert A. Forbes,
R. Berman,
Ross A. Baker
Publication year - 2012
Publication title -
primary care companion to cns disorders/the primary care companion for cns disorders
Language(s) - English
Resource type - Journals
eISSN - 2155-7772
pISSN - 2155-7780
DOI - 10.4088/pcc.12m01394
Subject(s) - aripiprazole , placebo , medicine , major depressive disorder , post hoc analysis , antidepressant , adjunctive treatment , psychology , psychiatry , schizophrenia (object oriented programming) , alternative medicine , pathology , amygdala , hippocampus
To evaluate the effect of adjunctive aripiprazole to antidepressant therapy (ADT) on functional outcomes, as assessed by the Sheehan Disability Scale (SDS).